drugset / Trial / NCT01694264
Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
Phase 3
Terminated
43 enrolled
Seoul National University Hospital
Ajou University School of Medicine · collabChonbuk National University Hospital · collabChonnam National University Hospital · collabChungnam National University Hospital · collabDaegu Catholic University Medical Center · collabDong-A University · collabEulji University Hospital · collabEwha Womans University Mokdong Hospital · collabGachon University Gil Medical Center · collabHallym University Medical Center · collabHanyang University · collabInha University Hospital · collabKonkuk University Medical Center · collabKorea University Guro Hospital · collabKyung Hee University Hospital at Gangdong · collabKyunghee University Medical Center · collabKyungpook National University Hospital · collabSMG-SNU Boramae Medical Center · collabSeverance Hospital · collabThe Catholic University of Korea · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
Analysis of effect of anti-TNFα treatment on HBV reactivation among patients with systemic rheumatic disease, especially rheumatoid arthritis
Timeline
- Start
- 2012-09-01
- Primary completion
- 2015-08-31
- Completion
- 2015-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entecavir | Small molecule | 0.5 mg | Oral |